This educational genetics webinar covers the clinical significance of cardiology-related secondary findings and the specific types of secondary findings related to cardiovascular phenotypes. We will delve into various conditions, including aortopathies, cardiomyopathies, and arrhythmias, and outline the next steps for clinical tests and family screening. Learn about the latest additions to the guidelines, the impact of these findings on patients and their families, as well as the next steps for clinical tests and family screening.
Key Topics
- Understanding the difference between secondary and incidental findings
- The value and types of secondary findings in cardiology
- Integrating family history and genetic testing results into the diagnostic evaluation of patients
- Managing the impact and uncertainties of genetic testing on patients and their families.
- Reviewing current clinical guidelines and their implications
Speakers
Dr. Allison Faber is head of Product and Customer Service at Arcensus. She has a background in research and diagnostic genetics. She completed a PhD in Physiology at the Medical College of Wisconsin and postdoctoral research at the Max Delbrück Center for Molecular Medicine.
Dr. Elena Jarvis is a Medical Advisor for Arcensus. She earned her medical degree from Albert-Ludwigs-University Freiburg, where she also completed her dissertation in the neurology department at University Hospital Freiburg. Over the past decade, she has specialized in family and internal medicine, with a focus on cardiovascular diseases. Currently, she leverages her extensive expertise as a freelance medical consultant, driving innovation in the MedTech sector.